Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fey SK"'
Autor:
Fey SK; CRUK Beatson Institute, Glasgow, United Kingdom., Najumudeen AK; Institute for Molecular Medicine Finland, Helsinki, Finland, Finland., Watt DM; CRUK Scotland Institute, Glasgow, United Kingdom., Millett LM; Cancer Research UK Beatson Institute, United Kingdom., Ford CA; Cancer Research UK Beatson Institute, Glasgow, Scotland, United Kingdom., Gilroy K; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Simpson RJ; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., McLay K; University of Glasgow, Glasgow, East Dunbartonshire, United Kingdom., Upstill-Goddard R; University of Glasgow, Glasgow, United Kingdom., Chang D; University of Glasgow, Glasgow, United Kingdom., Clark W; Beatson Institute for Cancer Research, Glasgow, United Kingdom., Nixon C; CRUK Scotland Institute, Glasgow, United Kingdom., Birch JL; University of Glasgow, Glasgow, East Dunbartonshire, United Kingdom., Barry ST; AstraZeneca (United Kingdom), Cambridge, United Kingdom., Morton JP; CRUK Beatson Institute, Glasgow, United Kingdom., Campbell AD; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Sansom OJ; CRUK Beatson Institute, Glasgow, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.
Autor:
Fey SK; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany., Vaquero-Siguero N; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Jackstadt R; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), 69120 Heidelberg, Germany; Cancer Progression and Metastasis Group, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany; German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, 69120 Heidelberg, Germany. Electronic address: r.jackstadt@dkfz.de.
Publikováno v:
Cell reports [Cell Rep] 2024 Jun 25; Vol. 43 (6), pp. 114270. Date of Electronic Publication: 2024 May 23.
Autor:
Najumudeen AK; Cancer Research UK Scotland Institute, Glasgow, UK. arafath.najumudeen@helsinki.fi.; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland. arafath.najumudeen@helsinki.fi., Fey SK; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Millett LM; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Ford CA; Cancer Research UK Scotland Institute, Glasgow, UK., Gilroy K; Cancer Research UK Scotland Institute, Glasgow, UK., Gunduz N; Cancer Research UK Scotland Institute, Glasgow, UK., Ridgway RA; Cancer Research UK Scotland Institute, Glasgow, UK., Anderson E; Cancer Research UK Scotland Institute, Glasgow, UK., Strathdee D; Cancer Research UK Scotland Institute, Glasgow, UK., Clark W; Cancer Research UK Scotland Institute, Glasgow, UK., Nixon C; Cancer Research UK Scotland Institute, Glasgow, UK., Morton JP; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Campbell AD; Cancer Research UK Scotland Institute, Glasgow, UK. a.campbell@beatson.gla.ac.uk., Sansom OJ; Cancer Research UK Scotland Institute, Glasgow, UK. o.sansom@beatson.gla.ac.uk.; School of Cancer Sciences, University of Glasgow, Glasgow, UK. o.sansom@beatson.gla.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 02; Vol. 15 (1), pp. 100. Date of Electronic Publication: 2024 Jan 02.
Autor:
Sharbeen G; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., McCarroll JA; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Australian Centre for Nanomedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales Sydney, New South Wales, Australia.; School of Women's and Children's Health, University of New South Wales Sydney, New South Wales, Australia., Akerman A; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Kopecky C; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Youkhana J; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Kokkinos J; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Australian Centre for Nanomedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales Sydney, New South Wales, Australia., Holst J; School of Medical Science and Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Boyer C; Australian Centre for Nanomedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales Sydney, New South Wales, Australia., Erkan M; Koc University Research Centre for Translational Medicine and Department of Surgery, Koc University, School of Medicine, Istanbul, Turkey., Goldstein D; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia.; Prince of Wales Hospital, Prince of Wales Clinical School, Sydney, New South Wales, Australia., Timpson P; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia., Cox TR; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia., Pereira BA; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia., Chitty JL; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales Sydney, Sydney, New South Wales, Australia., Fey SK; Cancer Research UK, Beatson Institute, Glasgow, United Kingdom., Najumudeen AK; Cancer Research UK, Beatson Institute, Glasgow, United Kingdom., Campbell AD; Cancer Research UK, Beatson Institute, Glasgow, United Kingdom., Sansom OJ; Cancer Research UK, Beatson Institute, Glasgow, United Kingdom., Ignacio RMC; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Naim S; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Liu J; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Russia N; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Lee J; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Chou A; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Department of Anatomical Pathology, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia., Johns A; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia., Gill AJ; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia.; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia., Gonzales-Aloy E; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Gebski V; NHMRC Clinical Trials Centre, University of Sydney, New South Wales, Australia., Guan YF; School of Medical Science and Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., Pajic M; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Australian Pancreatic Cancer Genome Initiative (APGI), Sydney, New South Wales, Australia., Turner N; School of Medical Sciences, University of New South Wales Sydney, New South Wales, Australia., Apte MV; Pancreatic Research Group, South Western Sydney Clinical School, University New South Wales and Ingham Institute for Applied Medical Research, Sydney, Australia., Davis TP; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australian Institute of Bioengineering & Nanotechnology, University of Queensland, Queensland, Australia., Morton JP; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Haghighi KS; Prince of Wales Hospital, Prince of Wales Clinical School, Sydney, New South Wales, Australia., Kasparian J; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia., McLean BJ; The Garvan Institute of Medical Research and the Kinghorn Cancer Centre, Sydney, New South Wales, Australia., Setargew YF, Phillips PA; Pancreatic Cancer Translational Research Group, Prince of Wales Clinical School and School of Medical Sciences, Lowy Cancer Research Centre, University of New South Wales Sydney, New South Wales, Australia. p.phillips@unsw.edu.au.; Australian Centre for Nanomedicine, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of New South Wales Sydney, New South Wales, Australia.
Publikováno v:
Cancer research [Cancer Res] 2021 Jul 01; Vol. 81 (13), pp. 3461-3479. Date of Electronic Publication: 2021 May 12.
Autor:
Pickering KA; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Gilroy K; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Cassidy JW; CRUK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK., Fey SK; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK., Najumudeen AK; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Zeiger LB; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK., Vincent DF; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Gay DM; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Johansson J; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Fordham RP; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Miller B; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Clark W; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Hedley A; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Unal EB; EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRC), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), 08003, Barcelona, Spain.; Institute for Theoretical Biology, Humboldt Universität zu Berlin, Berlin, Germany., Kiel C; EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRC), Barcelona, Spain., McGhee E; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Machesky LM; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK., Nixon C; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., Johnsson AE; The Babraham Institute, Babraham Hall, Babraham, Cambridge, CB22 3AT, UK., Bain M; IBAHCM and School of Veterinary Medicine, 464 Bearsden Road, Bearsden, Glasgow, G61 1QH, UK., Strathdee D; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK., van Hoof SR; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM) and Cancer Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.; Oncode Institute, Academic Medical Center, Amsterdam, The Netherlands., Medema JP; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM) and Cancer Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.; Oncode Institute, Academic Medical Center, Amsterdam, The Netherlands., Anderson KI; The Francis Crick Institute, Mill Hill Laboratory, London, NW7 1AA, UK., Brachmann SM; Novartis Institutes for BioMedical Research, Klybeckstrasse, 141, 4002, Basel, Switzerland., Stucke VM; Novartis Institutes for BioMedical Research, Klybeckstrasse, 141, 4002, Basel, Switzerland., Malliri A; CRUK Manchester Institute, 553 Wilmslow Road, Manchester, M20 4BX, UK., Drysdale M; Broad Institute, 415 Main St, Cambridge, MA, 02142, United States., Turner M; The Babraham Institute, Babraham Hall, Babraham, Cambridge, CB22 3AT, UK., Serrano L; EMBL/CRG Systems Biology Research Unit, Centre for Genomic Regulation (CRC), Barcelona, Spain., Myant K; Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, Crewe Road South, Edinburgh, EH4 2XR, UK. kevin.myant@igmm.ed.ac.uk., Campbell AD; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. a.campbell@beatson.gla.ac.uk., Sansom OJ; CRUK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. o.sansom@beatson.gla.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK. o.sansom@beatson.gla.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2021 Jan 04; Vol. 12 (1), pp. 56. Date of Electronic Publication: 2021 Jan 04.
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Autor:
Najumudeen AK; Cancer Research UK Beatson Institute, Glasgow, UK., Ceteci F; Cancer Research UK Beatson Institute, Glasgow, UK.; Georg Speyer Haus Institute for Tumour Biology and Experimental Therapy, Paul-Ehrlich-Straße, Frankfurt, Germany., Fey SK; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Hamm G; Imaging and data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Steven RT; National Physical Laboratory, Teddington, Middlesex, UK., Hall H; Cancer Research UK Beatson Institute, Glasgow, UK., Nikula CJ; National Physical Laboratory, Teddington, Middlesex, UK., Dexter A; National Physical Laboratory, Teddington, Middlesex, UK., Murta T; National Physical Laboratory, Teddington, Middlesex, UK., Race AM; Imaging and data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Institute of Medical Bioinformatics and Biostatistics, University of Marburg, Marburg, Germany., Sumpton D; Cancer Research UK Beatson Institute, Glasgow, UK., Vlahov N; Cancer Research UK Beatson Institute, Glasgow, UK., Gay DM; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Københavns Universitet, BRIC, Copenhagen, Denmark., Knight JRP; Cancer Research UK Beatson Institute, Glasgow, UK., Jackstadt R; Cancer Research UK Beatson Institute, Glasgow, UK.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine gGmbH (HI-STEM), Division of Cancer Progression and Metastasis, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany., Leach JDG; Cancer Research UK Beatson Institute, Glasgow, UK., Ridgway RA; Cancer Research UK Beatson Institute, Glasgow, UK., Johnson ER; Cancer Research UK Beatson Institute, Glasgow, UK., Nixon C; Cancer Research UK Beatson Institute, Glasgow, UK., Hedley A; Cancer Research UK Beatson Institute, Glasgow, UK., Gilroy K; Cancer Research UK Beatson Institute, Glasgow, UK., Clark W; Cancer Research UK Beatson Institute, Glasgow, UK., Malla SB; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Dunne PD; The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Rodriguez-Blanco G; Cancer Research UK Beatson Institute, Glasgow, UK., Critchlow SE; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Mrowinska A; Cancer Research UK Beatson Institute, Glasgow, UK., Malviya G; Cancer Research UK Beatson Institute, Glasgow, UK., Solovyev D; Cancer Research UK Beatson Institute, Glasgow, UK., Brown G; Cancer Research UK Beatson Institute, Glasgow, UK., Lewis DY; Cancer Research UK Beatson Institute, Glasgow, UK., Mackay GM; Cancer Research UK Beatson Institute, Glasgow, UK., Strathdee D; Cancer Research UK Beatson Institute, Glasgow, UK., Tardito S; Cancer Research UK Beatson Institute, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Gottlieb E; Cancer Research UK Beatson Institute, Glasgow, UK.; The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Takats Z; Department of Metabolism, Imperial College London, London, UK., Barry ST; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK., Goodwin RJA; Imaging and data Analytics, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK., Bunch J; National Physical Laboratory, Teddington, Middlesex, UK., Bushell M; Cancer Research UK Beatson Institute, Glasgow, UK., Campbell AD; Cancer Research UK Beatson Institute, Glasgow, UK., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK. o.sansom@beatson.gla.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. o.sansom@beatson.gla.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2021 Jan; Vol. 53 (1), pp. 16-26. Date of Electronic Publication: 2021 Jan 07.
Autor:
McGregor GH; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Campbell AD; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Fey SK; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Tumanov S; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Sumpton D; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Blanco GR; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Mackay G; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Nixon C; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Vazquez A; Cancer Research UK Beatson Institute, Glasgow, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, United Kingdom. jurre.kamphorst@glasgow.ac.uk o.sansom@beatson.gla.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Kamphorst JJ; Cancer Research UK Beatson Institute, Glasgow, United Kingdom. jurre.kamphorst@glasgow.ac.uk o.sansom@beatson.gla.ac.uk.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Rheos Medicines Inc, Cambridge, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2020 Jan 15; Vol. 80 (2), pp. 175-188. Date of Electronic Publication: 2019 Sep 27.